Non-coronary chest pain does not affect long-term mortality: a prospective, observational study using a matched population control by unknown
RESEARCH ARTICLE Open Access
Non-coronary chest pain does not affect
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Abstract
Background: Chest pain assumed to be of non-coronary origin (NCCP) may be linked to enhanced mortality due
to coronary heart disease (CHD). The aim of this study was to follow NCCP patients, as defined in primary care, with
respect to mortality and long-term morbidity of CHD. We further examined if NCCP associates with risk factors for
CHD.
Methods: Patients consulting general practitioners (GPs) in 1998–2000 in three primary care centers in the
southeast Sweden for chest pain regarded as NCCP were compared with controls matched for age, gender
and residential area. Causes of death were gathered from registry data and death certificates. In 2005 a postal
questionnaire was distributed to the survivors to collect demographic and clinical data. If participants had
CHD diagnosed by a physician prior to inclusion they were excluded.
Results: Patients with NCCP (n = 382) and population controls (n = 746) did not differ with respect to
mortality and incidence of CHD. The NCCP group reported more ongoing chest pain (OR 3.34 95 % CI 2.41–4.62),
they more often had elevated blood pressure (OR 1.86 95 % CI 1.32–2.60), consumed more β-blockers (p < 0.001),
aspirin (p = 0.013), thiazides (p = 0.004) and long-acting nitrates (p = 0.002). They further had more remedies
for acid-related disorders (p = 0.014) and obstructive pulmonary disease (p < 0.001).
Conclusions: The study suggests that individuals with chest pain judged by GPs to be NCCP do not develop
CHD more frequently than population controls. It is evident that NCCP often lasts for many years and that
the condition associates with hypertension.
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Background
Chest pain from causes other than coronary heart disease
(CHD) is widespread [1–3]. Non-specific or non-cardiac
chest pain is a heterogeneous condition defined as chest
pain of other cause than cardiac and not explained by
other well-established conditions [2, 4]. In this article we
have chosen to use the term non-coronary chest pain
(NCCP) since coronary heart disease (CHD) is the most
prevalent serious cause of chest pain and the number one
cause that clinical evaluation and investigations aim to
rule out. In primary care populations NCCP without
established CHD may imply an increased risk of subse-
quent CHD and death [5, 6]. There are various reports on
the time extension of NCCP [7, 8]. In the primary care
setting a majority of patients report chest pain for more
than 6 months [4]. Although NCCP-patients in some
studies have a good outcome concerning mortality they
may suffer a considerable morbidity [9, 10] and also
impaired quality of life [2, 11, 12]. Knowledge of long
term outcome of NCCP is limited and needs clarification
but female NCCP sufferers have a higher prevalence of
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cardiovascular risk factors [13]. In a previous study [14],
we defined patients consulting for chest pain that the
general practitioner (GP) regarded as less likely to be due
to CHD. They were followed for almost 6 years with the
aim to evaluate if they develop CHD more frequently
and if they have more risk factors for CHD.
Methods
Setting and participants
NCCP patients were selected from 1 suburban and 2
rural primary health care centres [14] serving the nearby
population. The catchment areas of the health care
centres were similar to the parishes as defined in the
Swedish National Population Registry. Patients were
included between May 1998 and April 2000 if they
consulted their GP for chest pain that started in the
previous 6 months and if they were between 20 and
79 years old. The inclusion involved 441 NCCP indi-
viduals and 50 patients judged as possible CHD. After
further clinical investigation 21 of the latter were assessed
as NCCP and thus 462 patients remained. Five of them
were excluded due to a previous history of CHD. Sixty-
two individuals below 35 years of age were kept out as
the risk for CHD in their age group was considered
to be very low. Two NCCP patients were excluded since
they had protected addresses and were impossible to con-
tact by regular mail. Due to an administrative failure one
further NCCP patient was excluded. Hence, 392 NCCP
patients remained for evaluation. In 2005, for each patient,
two controls matched for age, gender and residency area
were chosen from the Swedish National Population Regis-
try. The database contains data of all residents in Sweden,
identified by their unique personal identity number which
includes date of birth. In addition, for each individual the
database contains information about postal address, parish
of residency and if applicable, date of decease. For each
NCCP patient we chose two controls of same gender
being as close as possible in age and living in the same
primary health care catchment area. We did not include
unmatched cases in the study. Consequently, most con-
trol pairs had similar age as their NCCP counterpart but
it could differ up to 4 years. The controls were selected
in 2005 and given the same inclusion date (between
May 1998 and April 2000) as the corresponding case.
All subjects were alive when they entered the study.
Postal questionnaire
A postal questionnaire was used, on average 5 years and
11 months (SD ± 7 months) after the initial consultation,
to collect demographic data such as education, family
status and smoking habits. We inquired about chest pain
within the last 6 months. Questions were also asked
about acute CHD (myocardial infarctions and unstable
angina pectoris), angina pectoris, increased cholesterol
level and hypertension. The survey also assessed current
use of medication of all kinds and consultations for chest
pain in recent years.
Validation of clinical data
Causes of death were gathered from the Cause of Death
Registry and from death certificates for all deceased
participants. The medical records of the deceased were
checked for pre-mortem CHD. If participants reported
acute CHD and/or stable angina pectoris, their medical
records were reviewed. All charts were assessed blinded to
group allocation. Angina pectoris was diagnosed clinically
or the diagnosis was based on findings at coronary angiog-
raphy, exercise testing and/or myocardial perfusion scin-
tigraphy. Other medical conditions were not verified by
inspecting medical records.
Mortality analysis
The study originally included 392 patients with NCCP
and 784 controls. Ten patients with NCCP (six alive and
four dead) and 38 controls (27 alive and 11 dead) were
excluded because medical records revealed the presence
of CHD before inclusion. The remaining 382 NCCP
patients and 746 controls were assessed with respect
to mortality (Fig. 1).
Basis of NCCP classification
In 1998–2000, the 382 patients with NCCP were classi-
fied as such after clinical evaluation in 208 cases, after a
normal exercise test in 123 cases and after a normal
myocardial perfusion study in 19 cases. In addition, 32
cases were assessed as having a low likelihood for CHD
after examination at a nearby hospital.
Managing of patients according to the postal
questionnaire
A flowchart showing the management of the 392 pa-
tients with NCCP and the 784 controls is presented
in Fig. 1. The survey was not sent to the families of the
deceased individuals (20 NCCP patients and 39 controls).
The questionnaire was delivered by regular mail to the
remaining 372 patients and 745 controls. It was returned
by 285 patients (77 %) and 557 controls (75 %). Of these,
six individuals with assumed NCCP and 27 controls were
excluded as they had CHD diagnosed before inclusion.
Thus, 279 patients with NCCP and 530 controls remained
to be assessed.
Statistics
The Pearson chi-squared test and the Fisher exact test
were employed for nominal variables. The unpaired two-
tailed Student t-test was used for continuous data. Univa-
riate logistic regression was performed for “consultations
for chest pain in recent years” and clinical characteristics
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e.g. hypercholesterolemia as dependent variables and
NCCP or control as the predicting variable. Then multi-
variate regression was carried out with clinical characte-
ristics as dependent variables to adjust for age, sex and
“consultations for chest pain in recent years”. The level
of significance was set at p < 0.05. At the evaluation to
increase statistical power the matching was broken due
to the non-responders.
Results
Table 1 shows mortality rates almost 6 years after the
initial investigation by the GPs. All-cause mortality and
causes of death did not differ significantly between the
groups. The groups did not differ with respect to demo-
graphic data (Table 2). Patients with NCCP consulted
their GPs for chest pain more frequently (OR 4.45 95 %
CI 3.24–6.10) (Table 3) and they more often experienced
chest pain during the last 6 months (OR 3.34 95 % CI
2.41–4.62). The groups did not differ with respect to
self-reported acute CHD and stable angina pectoris
(Table 3). Patients with NCCP had more angina pectoris,
but the difference disappeared when adjusting for, “con-
sultations for chest pain in recent years”. Patients with
NCCP more often stated that they had increased choles-
terol levels but the difference was insignificant when
adjusting for “consultations for chest pain in recent years”
(OR 1.44 95 % CI 1.00–2.08). NCCP proved to be asso-
ciated with hypertension (OR 1.86 95 % CI 1.32–2.60)
(Table 3). In the multivariate analysis no gender difference
was found with respect to hypertension (OR 0.98 95 % CI
0.73.1.36). It is evident that NCCP patients consumed
more β-blockers (p < 0.001), thiazides (p = 0.004), aspirin
(p = 0.013) and long-acting nitrates (p = 0.002). They
Fig. 1 Flowchart showing the management of the 392 non-coronary chest pain (NCCP) patients and the 784 controls
Table 1 All-cause mortality and causes of death for the patients
with non-coronary chest pain (NCCP) and the population
controls
NCCP
(n = 382) (%)
Controls
(n = 746) (%)
P value
All-cause mortality 4.2 3.8 0.734
Cause of death
Cerebrovascular diseases 0.3 0.5 0.668
Coronary heart disease 0.5 1.1 0.509
Othera 2.9 1.7 0.222
Other diseases of the
circulatory system
0.5 0.4 1.000
aAccidents, neoplasms and diseases of the genitourinary, nervous and
respiratory systems
Table 2 Demographic characteristics for patients with
non-coronary chest pain (NCCP) and population controls,
according to the postal survey distributed in 2005
Patients with NCCP
(n = 279) (%)
Population controls
(n = 530) (%)
p-value
Age at inclusion
35–49 years (%) 27 29 0.778
50–59 years (%) 37 38
60–69 years (%) 24 21
70–79 years (%) 13 12
Sex (M/F) (%) 43/57 43/57 0.842








University (%) 17 18




aLess than 10 years in school
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further had more prescriptions for acid-related disorders
(p = 0.014) and obstructive pulmonary disease (p < 0.001)
(Table 4).
Discussion
The findings of this long-term follow-up of almost 6 years
of NCCP patients in primary care suggest that these
patients do not develop CHD more frequently than a
population control group matched for age, gender and
residential area (Table 3). The results also suggest that
NCCP does not affect mortality (Table 1). It is further
apparent that the condition often lasts for many years
and associates with hypertension (Table 3).
In this study the NCCP group was selected prospec-
tively and the controls retrospectively. In 2005, at study
end the groups did not differ with respect to the clinical
characteristics given in Table 2. They could be different
at inclusion and more importantly the groups may di-
verge regarding clinical features not being investigated
by us. At inclusion the index group was painstakingly
investigated by the GPs to exclude CHD whereas the
controls did not pass such an investigation. The handling
differs between groups making it tenable that some
controls had subclinical CHD unknown to us. The bias
most likely affects mortality and CHD frequency among
controls.
The most appropriate approach is to omit unsuitable
participants before inclusion and to use similar exclusion
strategies for both groups. It is further hazardous to
leave out participants post-hoc after groupings have
been defined. Limited resources made it impossible for
the GPs to investigate 784 apparently healthy controls
with respect to subclinical CHD. As a compromise, in
this study participants having pre-existing CHD were
identified and excluded in 2005. Individuals with severe
conditions more easily recall details about their disease
and clinical data shown in Table 3 are most likely com-
promised by recall biases. It is also tenable that individ-
uals frequently seeking medical attention have better
knowledge about risk factors for CHD.
We validated medical records if subjects noted CHD
in the postal questionnaire and excluded participants if
hospital charts verified such a condition prior to inclu-
sion. Especially among non-responding controls such
cases may be unidentified. Postal questionnaires with a
high degree of certainty exclude previous myocardial
infarction [15, 16] but it is reasonable that they are less
accurate in identifying angina pectoris. However, self-
reported angina pectoris matches data obtained from
medical records reasonably well [17]. Consequently, the
review of hospital charts was limited to subjects who
stated that they had a diagnosed CHD. To include symp-
toms of current relevance the survey asked for chest pain
occurring during the last 6 months. It is desirable to
match the groups for clinical data such as hypertension
as well. The Swedish National Population Registry does
not contain such information making the undertaking
impossible.
The NCCP condition associates with increased all
cause long-term mortality [5, 6]. NCCP patients with a
normal exercise test had lower mortality due to CHD
after 6 years than a general population control group
[18]. We failed to verify both findings (Table 1). Possible
explanations include that the GPs had easy access to
exercise testing and myocardial perfusion scintigraphy.
A previous study showed that patients with NCCP in
56 % of cases had persistent symptoms after 6 months
[4]. In our study, NCCP-patients reported chest pain
Table 3 Self-reported clinical characteristics of patients with non-coronary chest pain (NCCP) and population controls after 6 years
follow-up
NCCP (n = 279) (%) Controls (n = 530) (%) p-valuea ORa (95 % CI) p-valueb Adjusted ORb (95 % CI)
Consultations for chest pain
in recent yearsc
65 30 <0.001 4.45 (3.24; 6.10) N.A. N.A.
Chest pain symptoms during the
last 6 months
45 20 <0.001 3.34 (2.41; 4.62) N.A. N.A.
Self-reported angina pectorisd 8.6 4.7 0.01 2.44 (1.28; 4.62) 0.39 1.36 (0.68; 2.73)
Acute coronary syndromese 3.6 2.6 0.45 1.37 (0.60; 3.13) 0.43 0.70 (0.28; 1.70)
Stable angina pectorise 2.2 1.5 0.51 1.43 (0.49; 4.18) 0.67 0.78 (0.26; 2.38)
Diabetes mellitusd 7.7 8.4 0.73 0.91 (0.53; 1.56) 0.52 0.82 (0.45; 1.49)
Hypercholesterolemiad 30 20 0.001 1.76 (1.26; 2.47) 0.05 1.44 (1.00; 2.08)
Hypertensiond 51 34 <0.001 2.04 (1.51; 2.78) <0.001 1.86 (1.32; 2.60)
N.A. = Not Applicable
aUnivariate logistic regression
bMultivariate logistic regression. Estimates adjusted for age, sex and “Consultations for chest pain in recent years”. Goodness-of-fit was measured with
Nagelkerke’s R2
cNo specific time limit was given for “recent years”
dEver informed by a physician of having the disease
eInformation is validated through medical records
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symptoms after as long as 6 years in 45 % of cases
with a more than three-fold increased risk as compared
with population controls (Table 3). The current work also
reveals that hypertension is more widespread among
patients with NCCP (Table 3) but contrary to a previous
study we failed to show gender differences with respect to
hypertension [13]. Patient newly diagnosed with NCCP
frequently use drugs for acid-related disorders [5]. It is in
line with our findings. Chest wall syndromes are common
in primary care [19] but in our hands analgesic consump-
tion was low in both groups (Table 4). NCCP patients with
repeated healthcare consultations have a high incidence of
depressive symptoms and cardiac anxiety [12]. It disagrees
with current findings as anti-depressants or sedatives
prescriptions did not differ between groups (Table 4).
The persistence of complaints and increased consultation
rates suggest that NCCP belongs to the group of medically
unexplained physical symptoms. A linkage between NCCP,
health care utilisation and alexithymia, i.e. a difficulty
identifying or verbalizing emotions has been demon-
strated among men. Alexithymia was also shown to be
increasingly stable over time. Likewise, there was a link-
age between NCCP, health care utilisation and anxiety
sensitivity among women [20]. These circumstances under-
line the importance of a positive diagnosis of NCCP at an
early stage, to prevent unnecessary investigations and costly
health care utilization [9].
Initially, the study groups were matched for age, gender
and residential area. Due to the non-responders to the
postal questionnaire many NCCP patients were left with-
out control counterparts. To increase statistical power the
matching was then broken. Death certificates give the final
cause of death in conjunction with underlying conditions
(n = 2). They also document other medical conditions
contributing to death. However, the quality of death certif-
icates vary but it is unlikely that the bias differ between
study groups. In this case the primary care centers catch-
ment areas are identical to the parishes used by the
Swedish National Population Registry making it possible
to select patients and controls from the same geographical
area. Participants from 1 suburban and 2 rural healthcare
centres were included. It is possible that GPs supporting a
population with many social problems show less favourable
results.
Angina pectoris may have a different meaning to the
population than the strict medical sense and patients’
perceptions depend on the number of chest pain consul-
tations. Further, the belief of having augmented choles-
terol levels and hypertension also increases by more
medical consultations. Cardiovascular medication is fre-
quently administered when CHD is suspected. GPs may
later continue the therapy, for example with β-blockers,
due to increased blood pressure. It is also possible that
GPs do not delete prescriptions of long-acting nitrates
when the clinical evaluation fails to confirm the suspi-
cion of CHD.
Conclusions
This study suggests that patients with NCCP do not have
an enhanced risk for developing CHD but they demon-
strate increased prevalence of hypertension. Individuals
with NCCP have more prescriptions for β-blockers, thia-
zides, aspirin and long-acting nitrates. They also had more
drugs for acid-related disorders and obstructive pulmon-
ary disease. The condition often continues for many years
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Table 4 Medication taken by patients with non-coronary chest
pain (NCCP) and population controls after 6 years follow-up
according to the postal survey distributed in 2005
NCCP
(n = 279) (%)
Controls
(n = 530) (%)
p-value
ACE inhibitors 8.6 5.7 0.111
AII inhibitors 6.8 4.3 0.132
β-Blockers 27 16 <0.001
Ca2+-Blockers 8.6 6.6 0.299
Furosemide 6.5 6.0 0.816
Thiazides 15 8.5 0.004
Aspirin 18 11 0.013
Long-acting nitrates 4.7 1.1 0.002
Statins 13 9.2 0.078
Agents for acid-related disordersa 13 2.8 <0.001
Analgesics and NSAID 7.9 5.5 0.179
Anti-diabetic medication 4.7 4.2 0.735
COPD agents 7.5 3.6 0.014
Anti-depressants 7.9 6.0 0.317
Hypnotics and sedatives 10 8.1 0.358
ACE angiotensin-converting enzyme, AII angiotensin II, NSAID non-steroidal
anti-inflammatory drugs, COPD chronic obstructive pulmonary disease
aAntacids, H2-receptor antagonists and proton pump inhibitors
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